Oncology

A study offers crucial information on the risk factors and prevalence of cisplatin-induced hearing loss in young cancer patients.

The coronavirus disease 2019 (COVID-19) pandemic has impacted health care delivery in a variety of areas. A report investigates what’s happened with pediatric cancer delivery.

A look at the most recent treatments for sickle cell disease and the latest pediatric oncology approvals.

A 6-year-old boy presented to his pediatrician with clear drainage from his left eye for 1 to 2 days. He denied itchiness, pain, vision changes, nasal congestion, or history of allergies. What's the diagnosis?

A quality improvement sought to shorten the time to antibiotics in pediatric oncology patients who are suspected to have neutropenia.

Teenagers and young adults are a discrete group on cancer patients. A new report examines the trends of cancer in this group.

Cancer in adolescents and young adults isn’t common. What symptoms spur a visit that starts the path to diagnosis? A report provides some information.

Reporting symptom burden and pain can be fairly subjective and they can become even more subjective when reported by proxy. A report examines how caregiver reports vary from a child’s report during treatment of pediatric cancer.

Good communication is a necessity to ensure optimal care for children. A new report looks at what parents look for when communicating with clinicians during pediatric cancer experiences.

The human papillomavirus (HPV) vaccine is the key to a major public health victory, but the vaccine coverage has been less than effective. A report offers some answer to how parental intent has made an impact.

A new study examines whether dexrazoxane provides cardiac protection in pediatric patients with acute myeloid leukemia (AML).

COVID-19 can lead to severe illness in patients with underlying health conditions. A research letter indicates that children who have pediatric cancer may not be at risk of more serious disease.

Clinical trials have led to many improvements in pediatric cancer survival rates. However, a new study finds that enrollment rates in clinical trials are on the decline.

Paternal smoking before conception or during pregnancy are both associated with increased risk of acute lymphoblastic leukemia in offspring, and the risk is significant when daily smoking consumption is higher than a certain threshold, according to a recent meta-analysis.

Children who have acute lymphoblastic leukemia (ALL) can reduce their risk of infection by consuming a diet rich in fruits and vegetable, according to a new 2-year cohort study.

Gene therapies have ushered in an exciting new era of treatment for some of the most challenging pediatric conditions, and the results are most encouraging.

A cancer diagnosis no longer means the grim prognosis for children that once might have happened. However, 2 recent studies illustrate that although progress has been made, there is still opportunity to improve cancer survival rates.

This month’s spotlight is Pediatric Oncology as Contemporary Pediatrics sits down exclusively with pediatric oncologist Lisa Diller, MD, vice chair, Clinical Affairs, and medical director, Clinical Cancer and Blood Disorders Service Line, Dana-Farber Cancer Institute, Boston, Massachusetts, to discuss the one key condition for which she believes community pediatricians should be especially aware-retinoblastoma.

BRCA2 mutations already are linked to a number of cancer types, and now researchers have found that it could play a role in the development of childhood lymphomas, as well.

An innovative program helps adolescents and young adults (AYAs) hospitalized with cancer to cope with their disease and navigate their journey through treatment and beyond.

Some birth defects may carry an increased cancer risk, according to a recent report, but researchers stop short of recommending routine screening.

New predictive models may identify and help childhood cancer survivors at a higher risk for ischemic heart disease and stroke.

A child’s cancer diagnosis presents psychosocial issues that the community pediatrician needs to assess and treat for the total well-being of the child, siblings, and parents.

The progress in treating cancer in children has been revolutionary, and the evidence base for providing long-term psychosocial care for their families has grown as well.

Pediatricians have had concerns about the known risks of marijuana use in children. What’s next for kids with cancer?

Adults who have survived childhood cancer are about 10 years ahead of their peers in terms of developing hypertension, according to a new report.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a large retrospective cohort study published in the Journal of the American Academy of Dermatology that examined whether children with pediatric psoriasis are at increased risk of cancer and discusses 2 caveats to the findings.

The premise is to use a patient’s own genetic information to guide decisions for prevention, diagnosis, and treatment of disease and other health conditions.

Stratifying tumors by their clinical characteristics and underlying biology will enable future targeting of specific therapies for glioma in children.

A new customized therapy for acute lymphoblastic leukemia (ALL) offers high remission rates but at a substantial cost, and only at specialized cancer centers.